IL6 and cholangiocarcinoma: Interleukin 6 (IL6) is a key inflammatory mediator driving cholangiocarcinogenesis [22, 41] to a great extent through the activation of the signal transducer and activator or transcription-3 (STAT3) pathway in CCA tissues [25].